By Chris Wack
RVL Pharmaceuticals shares were up 9% to 60 cents after the company said its board of directors has been considering certain strategic alternatives.
The specialty pharmaceutical company said that these include discussions to buy a specific potential counterparty in an all-stock strategic transaction and discussions with potential…
Read the full article here
